Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts

Elevation Oncology logo

Elevation Oncology Earnings Summary

Elevation Oncology released Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.24, which missed the consensus estimate of -$0.20 by $0.04. With a trailing EPS of -$0.82, Elevation Oncology's earnings are expected to decrease next year, from ($0.84) to ($0.89) per share.

Upcoming Q2
Earnings Date
Nov. 4Before Market OpensEstimated
Consensus EPS
(May. 15)
-$0.20
Actual EPS
(May. 15)
-$0.24 Missed By -$0.04

Q1 2025 Earnings Resources

ELEV Upcoming Earnings

Elevation Oncology's next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules.

Get Elevation Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevation Oncology and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ELEV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Elevation Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.27-$0.21-$0.24
Q2 20254-$0.36-$0.21-$0.28
Q3 20254-$0.23-$0.21-$0.22
Q4 20254-$0.24-$0.17-$0.21
FY 2025 15 -$1.10 -$0.80 -$0.94
Q1 20261-$0.18-$0.18-$0.18
Q2 20261-$0.19-$0.19-$0.19
Q3 20261-$0.11-$0.11-$0.11
Q4 20261-$0.13-$0.13-$0.13

Elevation Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/4/2025
(Estimated)
--------
5/15/2025Q1 2025-$0.20-$0.24 -$0.04-$0.24--
3/6/2025Q4 2024-$0.22-$0.18+$0.04-$0.18--
11/6/2024--$0.20-$0.22 -$0.02-$0.22--
8/6/2024--$0.23-$0.18+$0.05-$0.18--
5/2/2024Q1 2024-$0.21-$0.23 -$0.02-$0.23--
3/6/2024Q4 2023-$0.21-$0.19+$0.02-$0.19--
11/2/2023Q3 2023-$0.34-$0.25+$0.09-$0.25--

Elevation Oncology Earnings - Frequently Asked Questions

Elevation Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on ELEV's earnings history.

In the previous quarter, Elevation Oncology (NASDAQ:ELEV) missed the analysts' consensus estimate of ($0.20) by $0.04 with a reported earnings per share (EPS) of ($0.24). Learn more on analysts' earnings estimate vs. ELEV's actual earnings.

Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$44.49 million. ELEV has generated -$0.82 earnings per share over the last four quarters.

Elevation Oncology's earnings are expected to decrease from ($0.84) per share to ($0.89) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ELEV) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners